Duchenne muscular dystrophy
Not recruitingStudy of BMN 351 given by intravenous infusion to evaluate safety and tolerability in patients with Duchenne Muscular Dystrophy
Study of BMN 351 given by intravenous infusion to evaluate safety and tolerability in patients with Duchenne Muscular Dystrophy
- Disease:Duchenne muscular dystrophy
Spain- Participants:0–17 years











